Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Treatment of hereditary angioedema: A review (CME)
Neeti Bhardwaj
,
Timothy J. Craig
Department of Pediatrics
Department of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of hereditary angioedema: A review (CME)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hereditary Angioedema
100%
United States
33%
C1 Esterase Inhibitor
33%
Ecallantide
33%
Icatibant
33%
On-demand Therapy
33%
Literature Search
16%
Recombinant
16%
Europe
16%
Patient Education
16%
Self-limiting
16%
Contact System
16%
Therapeutic Safety
16%
Therapeutic Potential
16%
Therapeutic Response
16%
Peri-procedural
16%
Acute Treatment
16%
C1 Inhibitor
16%
PubMed
16%
New Therapies
16%
Acute Attack
16%
Practicing Physicians
16%
Lack of Awareness
16%
Regular Follow-up
16%
Reliable Access
16%
Long-term Prophylaxis
16%
Autosomal Dominant Disorder
16%
Tissue Swelling
16%
Medication Follow-up
16%
Recurrent Attacks
16%
Medicine and Dentistry
Hereditary Angioedema
100%
Complement Component C1s Inhibitor
50%
Ecallantide
33%
Icatibant
33%
Awareness
16%
Drug Therapy
16%
Edema
16%
Treatment Response
16%
Autosomal Dominant Disorder
16%
Pharmacology, Toxicology and Pharmaceutical Science
Angioneurotic Edema
100%
Complement Component C1s Inhibitor
50%
Ecallantide
33%
Edema
16%